Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.1
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ (6,432) $ (3,440)
General and administrative (2,098) (3,933)
Total operating expenses (8,530) (7,373)
Operating loss (8,530) (7,373)
Interest expense, net (399) (1,039)
Adjustments to fair value of derivatives (878) 5,177
Other income, net 41 162
Total other (expense) / income (1,236) 4,300
Loss before income taxes (9,766) (3,073)
Income tax expense (123) (427)
Net loss $ (9,889) $ (3,500)
Net loss per share - basic $ (0.78) $ (0.29)
Net loss per share - diluted $ (0.78) $ (0.29)
Weighted average ordinary shares outstanding - basic 12,681,900 12,193,435
Weighted average ordinary shares outstanding-diluted 12,681,900 12,193,435
Statement of Comprehensive Income [Abstract]    
Net loss $ (9,889) $ (3,500)
Unrealized gain on marketable securities 219  
Comprehensive loss $ (9,670) $ (3,500)